Document:

Exhibit 10.2

 

THIS INSTRUMENT CONTAINS
AN AFFIDAVIT OF CONFESSION OF JUDGMENT PROVISION WHICH CONSTITUTES A WAIVER OF IMPORTANT RIGHTS BORROWER MAY HAVE AND ALLOWS THE
HOLDER TO OBTAIN A JUDGMENT AGAINST BORROWER WITHOUT ANY FURTHER NOTICE.

 

NEITHER THE ISSUANCE NOR
SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID
ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR
FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

	Principal Amount: $315,000.00	Issue Date: October 25, 2017 
	Purchase Price: $283,500.00	 
	Original Issue Discount: $31,500.00	 

 

CONVERTIBLE PROMISSORY NOTE

 

FOR VALUE
RECEIVED, DRONE USA, INC., a Delaware corporation (hereinafter called the “Borrower”), hereby promises to
pay to the order of CROWN BRIDGE PARTNERS, LLC, a New York limited liability company, or registered assigns (the “Holder”)
the principal sum of $315,000.00 (the “Principal Amount”), together with interest at the rate of ten percent (10%)
per annum, at maturity or upon acceleration or otherwise, as set forth herein (the “Note”). The consideration to the
Borrower for this Note is up to $283,500.00 (the “Consideration”). The Holder shall pay $94,500.00 of the Consideration
(the “First Tranche”) within a reasonable amount of time of the full execution of the transactional documents related
to this Note. At the closing of the First Tranche, the outstanding principal amount under this Note shall be $105,000.00, consisting
of the First Tranche plus the prorated portion of the OID (as defined herein). The Holder may pay, in its sole discretion, such
additional amounts of the Consideration and at such dates as the Holder may choose in its sole discretion. THE PRINCIPAL SUM
DUE TO THE HOLDER SHALL BE PRORATED BASED ON THE CONSIDERATION ACTUALLY PAID BY THE HOLDER, THE APPLICABLE PORTION OF THE OID,
AS WELL AS THE APPLICABLE FEES AND INTEREST. The maturity date for each tranche funded shall be twelve (12) months from the
effective date of each payment (each a “Maturity Date”), and is the date upon which the principal sum of each respective
tranche, as well as any accrued and unpaid interest and other fees relating to that respective tranche, shall be due and payable.
This Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest
on this Note, which is not paid by the Maturity Date, shall bear interest at the rate of the lesser of (i) twelve percent (12%)
per annum or (ii) the maximum amount permitted by law from the due date thereof until the same is paid (“Default Interest”).
Interest shall commence accruing on the date that the Note is fully paid and shall be computed on the basis of a 365-day year and
the actual number of days elapsed. All payments due hereunder (to the extent not converted into the Borrower’s common stock
(the “Common Stock”) in accordance with the terms hereof) shall be made in lawful money of the United States of America.
All payments shall be made at such address as the Holder shall hereafter give to the Borrower by written notice made in accordance
with the provisions of this Note. Whenever any amount expressed to be due by the terms of this Note is due on any day which is
not a business day, the same shall instead be due on the next succeeding day which is a business day and, in the case of any interest
payment date which is not the date on which this Note is paid in full, the extension of the due date thereof shall not be taken
into account for purposes of determining the amount of interest due on such date. As used in this Note, the term “business
day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York
are authorized or required by law or executive order to remain closed.

 

    	 	1	 

     

    

 

This Note
carries a prorated original issue discount of $31,500.00 (the “OID”), to cover the Holder’s accounting fees,
due diligence fees, monitoring, and/or other transactional costs incurred in connection with the purchase and sale of the Note,
which is included in the principal balance of this Note. Thus, the purchase price of this Note shall be $283,500.00, computed as
follows: the Principal Amount minus the OID.

 

This Note
is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.

 

The following additional terms shall apply to this Note:

 

ARTICLE I. CONVERSION RIGHTS

 

1.1         Conversion
Right. The Holder shall have the right at any time to convert all or any part of the outstanding and unpaid principal amount
and accrued and unpaid interest of this Note into fully paid and non-assessable shares of Common Stock, as such Common Stock exists
on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall hereafter
be changed or reclassified at the conversion price (the “Conversion Price”) determined as provided herein (a “Conversion”);
provided, however, that in no event shall the Holder be entitled to convert any portion of this Note in excess of
that portion of this Note upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned
by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership
of the unconverted portion of the Notes or the unexercised or unconverted portion of any other security of the Borrower subject
to a limitation on conversion or exercise analogous to the limitations contained herein) and (2) the number of shares of Common
Stock issuable upon the conversion of the portion of this Note with respect to which the determination of this proviso is being
made, would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common
Stock. For purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulations 13D-G
thereunder, except as otherwise provided in clause (1) of such proviso, provided, further, however, that
the limitations on conversion may be waived by the Holder upon, at the election of the Holder, not less than 61 days’ prior
notice to the Borrower, and the provisions of the conversion limitation shall continue to apply until such 61st day (or such later
date, as determined by the Holder, as may be specified in such notice of waiver). The number of shares of Common Stock to be issued
upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the applicable Conversion
Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit A (the “Notice
of Conversion”), delivered to the Borrower or Borrower’s transfer agent by the Holder in accordance with Section 1.4
below; provided that the Notice of Conversion is submitted by facsimile or e-mail (or by other means resulting in, or reasonably
expected to result in, notice) to the Borrower or Borrower’s transfer agent before 6:00 p.m., New York, New York time on
such conversion date (the “Conversion Date”). The term “Conversion Amount” means, with respect to any
conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion plus (2) at
the Holder’s option, accrued and unpaid interest, if any, on such principal amount at the interest rates provided in this
Note to the Conversion Date, plus (3) at the Holder’s option, Default Interest, if any, on the amounts referred to
in the immediately preceding clauses (1) and/or (2) plus (4) at the Holder’s option, any amounts owed to the Holder
pursuant to Sections 1.3 and 1.4(g) hereof.

 

    	 	2	 

     

    

 

1.2          Conversion
Price.

 

(a)          Calculation
of Conversion Price. The Conversion Price shall be the Variable Conversion Price (as defined herein) (subject to equitable
adjustments for stock splits, stock dividends or rights offerings by the Borrower relating to the Borrower’s securities
or the securities of any subsidiary of the Borrower, combinations, recapitalization, reclassifications, extraordinary distributions
and similar events) (also subject to adjustment as further described herein). The "Variable Conversion Price" shall
mean 65% multiplied by the Market Price (as defined herein) (representing a discount rate of 35%). “Market Price”
means the lowest one (1) Trading Price (as defined below) for the Common Stock during the twenty (20) Trading Day period ending
on the last complete Trading Day prior to the Conversion Date. “Trading Price” means, for any security as of any date,
the lowest traded price on the Over-the-Counter Pink Marketplace, OTCQB, or applicable trading market (the “OTCQB”)
as reported by a reliable reporting service (“Reporting Service”) designated by the Holder (i.e. Bloomberg) or, if
the OTCQB is not the principal trading market for such security, on the principal securities exchange or trading market where
such security is listed or traded or, if the lowest intraday trading price of such security is not available in any of the foregoing
manners, the lowest intraday price of any market makers for such security that are quoted on the OTC Markets. If the Trading Price
cannot be calculated for such security on such date in the manner provided above, the Trading Price shall be the fair market value
as mutually determined by the Borrower and the holders of a majority in interest of the Notes being converted for which the calculation
of the Trading Price is required in order to determine the Conversion Price of such Notes. “Trading Day” shall mean
any day on which the Common Stock is tradable for any period on the OTCQB, or on the principal securities exchange or other securities
market on which the Common Stock is then being traded. If at any time while this Note is outstanding, the Conversion Price is
equal to or lower than $0.05, then an additional ten percent (10%) discount shall be factored into the Conversion Price until
this Note is no longer outstanding (resulting in a discount rate of 45% assuming no other adjustments are triggered hereunder).
In the event that shares of the Borrower’s Common Stock are not deliverable via DWAC following the conversion of any amount
hereunder, an additional ten percent (10%) discount shall be factored into the Variable Conversion Price until this Note is no
longer outstanding (resulting in a discount rate of 45% assuming no other adjustments are triggered hereunder). Additionally,
if the Borrower fails to comply with the reporting requirements of the Exchange Act (including but not limited to becoming late
or delinquent in its filings, even if the Borrower subsequently cures such delinquency) at any time while after the Issue Date,
and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act, an additional fifteen percent
(15%) discount shall be factored into the Variable Conversion Price until this Note is no longer outstanding (resulting in a discount
rate of 50% assuming no other adjustments are triggered hereunder).

  

Each time,
while this Note is outstanding, the Borrower enters into a Section 3(a)(9) transaction (including but not limited to the issuance
of new promissory notes or of a replacement promissory note), or Section 3(a)(10) transaction, in which any 3rd
party has the right to convert monies owed to that 3rd party (or receive shares pursuant
to a settlement or otherwise) at a discount to market greater than the Variable Conversion Price in effect at that time (prior
to all other applicable adjustments in the Note), then the Variable Conversion Price shall be automatically adjusted to such greater
discount percentage (prior to all applicable adjustments in this Note) until this Note is no longer outstanding. Each time, while
this Note is outstanding, the Borrower enters into a Section 3(a)(9) transaction (including but not limited to the issuance of
new promissory notes or of a replacement promissory note), or Section 3(a)(10) transaction, in which any 3rd
party has a look back period greater than the look back period in effect under the Note at that time, then the Holder’s
look back period shall automatically be adjusted to such greater number of days until this Note is no longer outstanding. The Borrower
shall give written notice to the Holder, with the adjusted Variable Conversion Price and/or adjusted look back period (each adjustment
that is applicable due to the triggering event), within one (1) business day of an event that requires any adjustment described
in the two immediately preceding sentences.

 

Holder shall be
entitled to deduct $500.00 from the conversion amount in each Notice of Conversion to cover Holder’s deposit fees associated
with each Notice of Conversion.

  

    	 	3	 

     

    

 

If at any time the
Conversion Price as determined hereunder for any conversion would be less than the par value of the Common Stock, then at the sole
discretion of the Holder, the Conversion Price hereunder may equal such par value for such conversion and the Conversion Amount
for such conversion may be increased to include Additional Principal, where “Additional Principal” means such additional
amount to be added to the Conversion Amount to the extent necessary to cause the number of conversion shares issuable upon such
conversion to equal the same number of conversion shares as would have been issued had the Conversion Price not been adjusted by
the Holder to the par value price.

 

(b)          Authorized
Shares. The Borrower covenants that during the period the conversion right exists, the Borrower will reserve from its authorized
and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock
upon the full conversion of this Note. The Borrower is required at all times to have authorized and reserved eight times the number
of shares that is actually issuable upon full conversion of the Note (based on the Conversion Price of the Notes in effect from
time to time)(the “Reserved Amount”). The Reserved Amount shall be increased from time to time in accordance with
the Borrower’s obligations hereunder. The Borrower represents that upon issuance, such shares will be duly and validly issued,
fully paid and non-assessable. In addition, if the Borrower shall issue any securities or make any change to its capital structure
which would change the number of shares of Common Stock into which the Notes shall be convertible at the then current Conversion
Price, the Borrower shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares
of Common Stock authorized and reserved, free from preemptive rights, for conversion of the outstanding Notes. The Borrower (i)
acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Common Stock issuable upon conversion
of this Note, and (ii) agrees that its issuance of this Note shall constitute full authority to its officers and agents who are
charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock
in accordance with the terms and conditions of this Note.

 

If, at any time the Borrower does
not maintain the Reserved Amount it will be considered an Event of Default under Section 3.2 of the Note.

 

1.3         Method
of Conversion.

 

(a)          Mechanics
of Conversion. Subject to Section 1.1, this Note may be converted by the Holder in whole or in part at any time from time
to time after the Issue Date, by (A) submitting to the Borrower a Notice
of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion Date prior to 6:00
p.m., New York, New York time) and (B) subject to Section 1.4(b), surrendering this Note at the principal office of the Borrower.

 

(b)          Surrender
of Note Upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance
with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire unpaid
principal amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount
so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower,
so as not to require physical surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such
records of the Borrower shall, prima facie, be controlling and determinative in the absence of manifest error. Notwithstanding
the foregoing, if any portion of this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder
first physically surrenders this Note to the Borrower, whereupon the Borrower will forthwith issue and deliver upon the order
of the Holder a new Note of like tenor, registered as the Holder (upon payment by the Holder of any applicable transfer taxes)
may request, representing in the aggregate the remaining unpaid principal amount of this Note. The Holder and any assignee, by
acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a
portion of this Note, the unpaid and unconverted principal amount of this Note represented by this Note may be less than the amount
stated on the face hereof.

 

    	 	4	 

     

    

 

(c)          Payment
of Taxes. The Borrower shall not be required to pay any tax which may be payable in respect of any transfer involved in the
issue and delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other than that
of the Holder (or in street name), and the Borrower shall not be required to issue or deliver any such shares or other securities
or property unless and until the person or persons (other than the Holder or the custodian in whose street name such shares are
to be held for the Holder’s account) requesting the issuance thereof shall have paid to the Borrower the amount of any such
tax or shall have established to the satisfaction of the Borrower that such tax has been paid.

 

(d)          Delivery
of Common Stock Upon Conversion. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or other
reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section
1.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates
for the Common Stock issuable upon such conversion within two (2) business days after such receipt (the “Deadline”)
(and, solely in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with
the terms hereof.

 

(e)          Obligation
of Borrower to Deliver Common Stock. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to
be the holder of record of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of
accrued and unpaid interest on this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its
obligations under this Article I, all rights with respect to the portion of this Note being so converted shall forthwith terminate
except the right to receive the Common Stock or other securities, cash or other assets, as herein provided, on such conversion.
If the Holder shall have given a Notice of Conversion as provided herein, the Borrower’s obligation to issue and deliver
the certificates for Common Stock shall be absolute and unconditional, irrespective of the absence of any action by the Holder
to enforce the same, any waiver or consent with respect to any provision thereof, the recovery of any judgment against any person
or any action to enforce the same, any failure or delay in the enforcement of any other obligation of the Borrower to the holder
of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder of
any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation of the
Borrower to the Holder in connection with such conversion. The Conversion Date specified in the Notice of Conversion shall be
the Conversion Date so long as the Notice of Conversion is received by the Borrower before 6:00 p.m., New York, New York time,
on such date.

 

    	 	5	 

     

    

 

(f)           Delivery
of Common Stock by Electronic Transfer. In lieu of delivering physical certificates representing the Common Stock issuable
upon conversion, provided the Borrower is participating in the Depository Trust Company (“DTC”) Fast Automated Securities
Transfer (“FAST”) program, upon request of the Holder and its compliance with the provisions contained in Section
1.1 and in this Section 1.4, the Borrower shall use its best efforts to cause its transfer agent to electronically transmit the
Common Stock issuable upon conversion to the Holder by crediting the account of Holder’s Prime Broker with DTC through its
Deposit Withdrawal Agent Commission (“DWAC”) system.

 

(g)          Failure
to Deliver Common Stock Prior to Deadline. Without in any way limiting the Holder’s right to pursue other remedies,
including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion
of this Note is not delivered by the Deadline (other than a failure due to the circumstances described in Section 1.3 above, which
failure shall be governed by such Section) the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the
Deadline that the Borrower fails to deliver such Common Stock. Such cash amount shall be paid to Holder by the fifth day of the
month following the month in which it has accrued or, at the option of the Holder (by written notice to the Borrower by the first
day of the month following the month in which it has accrued), shall be added to the principal amount of this Note, in which event
interest shall accrue thereon in accordance with the terms of this Note and such additional principal amount shall be convertible
into Common Stock in accordance with the terms of this Note. The Borrower agrees that the right to convert is a valuable right
to the Holder. The damages resulting from a failure, attempt to frustrate, interference with such conversion right are difficult
if not impossible to qualify. Accordingly the parties acknowledge that the liquidated damages provision contained in this Section
1.4(g) are justified.

 

(h)          DTC;
Market Loss. If the Borrower fails to maintain its status as “DTC Eligible” for any reason, or, if at any time
while this Note is outstanding the Conversion Price is equal to or lower than $0.01, then an additional fifteen percent (15%)
discount shall be factored into the Variable Conversion Price until this Note is no longer outstanding (resulting in a discount
rate of 60%, assuming no other adjustments are triggered hereunder except for the additional ten percent (10%) discount due to
the Conversion Price being equal to or lower than $0.05 as provided in Section 1.2 of this note).

 

1.4         Concerning
the Shares. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred unless (i) such
shares are sold pursuant to an effective registration statement under the Act or (ii) the Borrower or its transfer agent shall
have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant
to an exemption from such registration or (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor
rule) (“Rule 144”) or (iv) such shares are transferred to an “affiliate” (as defined in Rule 144) of the
Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 1.5 and who is an Accredited
Investor. Except as otherwise provided (and subject to the removal provisions set forth below), until such time as the shares
of Common Stock issuable upon conversion of this Note have been registered under the Act or otherwise may be sold pursuant to
Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each
certificate for shares of Common Stock issuable upon conversion of this Note that has not been so included in an effective registration
statement or that has not been sold pursuant to an effective registration statement or an exemption that permits removal of the
legend, shall bear a legend substantially in the following form, as appropriate:

 

    	 	6	 

     

    

 

“NEITHER THE ISSUANCE
AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID
ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR
FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

The legend
set forth above shall be removed and the Borrower shall issue to the Holder a new certificate therefore free of any transfer legend
if (i) the Borrower or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for
opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Common Stock may be made without
registration under the Act, which opinion shall be accepted by the Borrower so that the sale or transfer is effected or (ii) in
the case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by the Holder under an
effective registration statement filed under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to
the number of securities as of a particular date that can then be immediately sold. In the event that the Borrower does not accept
the opinion of counsel provided by the Holder with respect to the transfer of Securities pursuant to an exemption from registration,
such as Rule 144 or Regulation S, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2 of the Note.

 

1.5          [Intentionally
Omitted].

 

1.6          Status
as Shareholder. Upon submission of a Notice of Conversion by a Holder, (i) the shares covered thereby (other than the shares,
if any, which cannot be issued because their issuance would exceed such Holder’s allocated portion of the Reserved Amount
or Maximum Share Amount) shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a Holder
of such converted portion of this Note shall cease and terminate, excepting only the right to receive certificates for such shares
of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure
by the Borrower to comply with the terms of this Note. Notwithstanding the foregoing, if a Holder has not received certificates
for all shares of Common Stock prior to the tenth (10th) business day after the expiration of the Deadline with respect to a conversion
of any portion of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of Common
Stock by so notifying the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted
portions of this Note and the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if the Note
has not been surrendered, adjust its records to reflect that such portion of this Note has not been converted. In all cases, the
Holder shall retain all of its rights and remedies (including, without limitation, (i) the right to receive Conversion Default
Payments pursuant to Section 1.3 to the extent required thereby for such Conversion Default and any subsequent Conversion Default
and (ii) the right to have the Conversion Price with respect to subsequent conversions determined in accordance with Section 1.3)
for the Borrower’s failure to convert this Note.

 

    	 	7	 

     

    

 

ARTICLE II. CERTAIN COVENANTS

 

2.1          Distributions
on Capital Stock. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without the Holder’s
written consent (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash, property
or other securities) on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional
shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution in respect
of its capital stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority
of the Borrower’s disinterested directors.

 

2.2          Restriction
on Stock Repurchases. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without the
Holder’s written consent redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other
securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Borrower
or any warrants, rights or options to purchase or acquire any such shares.

 

ARTICLE III. EVENTS OF DEFAULT

 

If any of the following events of default (each, an “Event
of Default”) shall occur:

 

3.1          Failure
to Pay Principal or Interest. The Borrower fails to pay the principal hereof or interest thereon when due on this Note, whether
at maturity, upon acceleration or otherwise, and such breach continues for a period of five (5) days.

 

3.2          Conversion
and the Shares. The Borrower fails to reserve a sufficient amount of shares of common stock as required under the terms of
this Note (including Section 1.3 of this Note) and such breach continues for a period of five (5) days, fails to issue shares
of Common Stock to the Holder (or announces or threatens in writing that it will not honor its obligation to do so) upon exercise
by the Holder of the conversion rights of the Holder in accordance with the terms of this Note, fails to transfer or cause its
transfer agent to transfer (issue) (electronically or in certificated form) shares of Common Stock issued to the Holder upon conversion
of or otherwise pursuant to this Note as and when required by this Note, the Borrower directs its transfer agent not to transfer
or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) shares
of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this
Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from
removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any shares of Common Stock
issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written
announcement, statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure
shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in
writing) for two (2) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower
to remain current in its obligations to its transfer agent. It shall be an event of default of this Note, if a conversion of this
Note is delayed, hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the Holder,
the Holder advances any funds to the Borrower’s transfer agent in order to process a conversion, such advanced funds shall
be paid by the Borrower to the Holder within five (5) business days of a demand from the Holder, either in cash or as an addition
to the balance of the Note, and such choice of payment method is at the discretion of the Borrower.

 

    	 	8	 

     

    

 

3.3          Breach
of Covenants. The Borrower breaches any material covenant or other material term or condition contained in this Note and any
collateral documents and such breach continues for a period of ten (10) days after written notice thereof to the Borrower from
the Holder.

 

3.4          Breach
of Representations and Warranties. Any representation or warranty of the Borrower made herein or in any agreement, statement
or certificate given in writing pursuant hereto or in connection herewith, shall be false or misleading in any material respect
when made and the breach of which has (or with the passage of time will have) a material adverse effect on the rights of the Holder
with respect to this Note.

 

3.5          Receiver
or Trustee. The Borrower or any subsidiary of the Borrower shall make an assignment for the benefit of creditors, or apply
for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such
a receiver or trustee shall otherwise be appointed.

 

3.6          Judgments.
Any money judgment, writ or similar process shall be entered or filed against the Borrower or any subsidiary of the Borrower or
any of its property or other assets for more than $50,000, and shall remain unvacated, unbonded or unstayed for a period of twenty
(20) days unless otherwise consented to by the Holder, which consent will not be unreasonably withheld.

 

3.7          Bankruptcy.
Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under
any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary of the
Borrower.

 

3.8          Delisting
of Common Stock. The Borrower shall fail to maintain the listing or quotation of the Common Stock on the OTCQB or an equivalent
replacement exchange, the Nasdaq Global Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT.

 

    	 	9	 

     

    

 

3.9          Failure
to Comply with the Exchange Act. The Borrower shall fail to comply with the reporting requirements of the Exchange Act (including
but not limited to becoming late or delinquent in its filings at any time while this Note is outstanding, even if the Borrower
subsequently cures such delinquency), and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange
Act.

 

3.10        Liquidation.
Any dissolution, liquidation, or winding up of Borrower or any substantial portion of its business.

 

3.11        Cessation
of Operations. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its debts
as such debts become due, provided, however, that any disclosure of the Borrower’s ability to continue as a “going
concern” shall not be an admission that the Borrower cannot pay its debts as they become due, or any disposition or conveyance
of any material asset of the Company.

 

3.12        Financial
Statement Restatement. The Borrower replaces its auditor, or any restatement of any financial statements filed by the Borrower
with the SEC for any date or period from two years prior to the Issue Date of this Note and until this Note is no longer outstanding,
if the result of such restatement would, by comparison to the unrestated financial statement, have constituted a material adverse
effect on the rights of the Holder with respect to this Note.

 

3.13        Replacement
of Transfer Agent. In the event that the Borrower replaces its transfer agent, and the Borrower fails to provide prior to
the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions (including but not limited to
the provision to irrevocably reserve shares of Common Stock in the Reserved Amount) signed by the successor transfer agent to
Borrower and the Borrower.

 

3.14        Cross-Default.
Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a breach or default
by the Borrower of any covenant or other term or condition contained in any of the other financial instrument, including but not
limited to all convertible promissory notes, currently issued, or hereafter issued, by the Borrower, to the Holder or any other
3rd party (the “Other Agreements”), after the passage of all applicable notice and cure or grace periods,
shall, at the option of the Holder, be considered a default under this Note, in which event the Holder shall be entitled to apply
all rights and remedies of the Holder under the terms of this Note by reason of a default under said Other Agreement or hereunder.

 

3.15        Inside
Information. Any attempt by the Borrower or its officers, directors, and/or affiliates to transmit, convey, disclose, or any
actual transmittal, conveyance, or disclosure by the Borrower or its officers, directors, and/or affiliates of, material non-public
information concerning the Borrower, to the Holder or its successors and assigns, which is not immediately cured by Borrower’s
filing of a Form 8-K pursuant to Regulation FD on that same date.

 

    	 	10	 

     

    

 

3.16        No
bid. At any time while this Note is outstanding, the lowest Trading Price on the OTCQB or other applicable principal trading
market for the Common Stock is equal to or less than $0.0001.

 

Upon the
occurrence and during the continuation of any Event of Default specified in Sections 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9,
3.10, 3.11, 3.12, 3.13, 3.14, 3.15, and/or 3.16 exercisable through the delivery of written notice to the Borrower by such Holders
(the “Default Notice”), and upon the occurrence of an Event of Default specified the remaining sections of Articles
III, the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations
hereunder, an amount equal to 150% multiplied by the then outstanding entire balance of the Note (including principal and
accrued and unpaid interest) plus Default Interest, if any, plus any amounts owed to the Holder pursuant to Sections
1.4(g) hereof (collectively, in the aggregate of all of the above, the “Default Amount”), and all other amounts payable
hereunder shall immediately become due and payable, all without demand, presentment or notice, all of which hereby are expressly
waived, together with all costs, including, without limitation, legal fees and expenses, of collection, and the Holder shall be
entitled to exercise all other rights and remedies available at law or in equity.

 

The Holder
shall have the right at any time, to require the Borrower, upon written notice, to immediately issue, in lieu of the Default Amount,
the number of shares of Common Stock of the Borrower equal to the Default Amount divided by the Conversion Price then in effect,
subject to issuance in tranches due to the beneficial ownership limitations contained in this Note.

 

Holder’s
Right to Confession of Judgment.  Upon the occurrence of any Event of Default under the Note, and in addition to any other
right or remedy of the Holder hereunder, under the related transaction documents, or otherwise at law or in equity, the Borrower
hereby irrevocably authorizes and empowers Holder or its legal counsel, each as the Borrower’s attorney-in-fact, to appear ex
parte and without notice to the Borrower to confess judgment (attached hereto as Exhibit B) against the Borrower for the
unpaid amount of this Note. The judgment shall set forth the amount then due hereunder, plus attorney’s fees and cost of
suit, and to release all errors, and waive all rights of appeal. The Borrower waives the right to contest Holder’s rights
under this section, including without limitation the right to any stay of execution and the benefit of all exemption laws now or
hereafter in effect. No single exercise of the foregoing right and power to confess judgment will be deemed to exhaust such power,
whether or not any such exercise shall be held by any court to be invalid, voidable, or void, and such power shall continue undiminished
and may be exercised from time to time as the Holder may elect until all amounts owing on this Note have been paid in full.

 

    	 	11	 

     

    

 

ARTICLE IV. MISCELLANEOUS

 

4.1          Failure
or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other
or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative
to, and not exclusive of, any rights or remedies otherwise available.

 

4.2          Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, facsimile, or electronic mail addressed as set forth below or to such other address as such party
shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder
shall be deemed effective (a) upon hand delivery, upon electronic mail delivery, or delivery by facsimile, with accurate confirmation
generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during
normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following
the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur. The addresses for such communications shall be:

 

If to the Borrower, to:

 

DRONE USA, INC.

16 Hamilton Street

West Haven, CT 06516

e-mail: grant@droneusainc.com

 

If to the Holder:

 

CROWN BRIDGE PARTNERS, LLC

1173a 2nd Avenue,
Suite 126 

New York, NY 10065

e-mail: Info@CrownBridgeCapital.com

 

    	 	12	 

     

    

 

4.3          Amendments.
This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the Holder. The
term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument as originally
executed, or if later amended or supplemented, then as so amended or supplemented.

 

4.4          Assignability.
This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit of the Holder and
its successors and assigns. Each transferee of this Note must be an “accredited investor” (as defined in Rule 501(a)
of the 1933 Act). Notwithstanding anything in this Note to the contrary, this Note may be pledged as collateral in connection
with a bona fide margin account or other lending arrangement.

 

4.5          Cost
of Collection. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof costs of collection,
including reasonable attorneys’ fees.

 

4.6          Governing
Law. This Note shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles
of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note
shall be brought only in the state and/or federal courts of New York City, NY. The parties to this Note hereby irrevocably waive
any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction
or venue or based upon forum non conveniens. The Borrower and Holder waive trial by jury. The prevailing party shall be
entitled to recover from the other party its reasonable attorney's fees and costs. In the event that any provision of this Note
or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law,
then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the
validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process
and consents to process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction
Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law.

 

    	 	13	 

     

    

 

4.7          Certain
Amounts. Whenever pursuant to this Note the Borrower is required to pay an amount in excess of the outstanding principal amount
(or the portion thereof required to be paid at that time) plus accrued and unpaid interest plus Default Interest on such
interest, the Borrower and the Holder agree that the actual damages to the Holder from the receipt of cash payment on this Note
may be difficult to determine and the amount to be so paid by the Borrower represents stipulated damages and not a penalty and
is intended to compensate the Holder in part for loss of the opportunity to convert this Note and to earn a return from the sale
of shares of Common Stock acquired upon conversion of this Note at a price in excess of the price paid for such shares pursuant
to this Note. The Borrower and the Holder hereby agree that such amount of stipulated damages is not plainly disproportionate
to the possible loss to the Holder from the receipt of a cash payment without the opportunity to convert this Note into shares
of Common Stock.

 

4.8          Remedies.
The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at law for
a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the
Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law
or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing
any breach of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic
loss and without any bond or other security being required.

 

4.9          Prepayment.
Notwithstanding anything to the contrary contained in this Note, the Borrower may prepay any amount outstanding under this Note,
during the initial 30 day period after the issuance of this Note, by making a payment to the Holder of an amount in cash equal
to 112% multiplied the amount that the Borrower is prepaying, subject to the Holder’s prior written acceptance in Holder’s
sole discretion. Notwithstanding anything to the contrary contained in this Note, the Borrower may prepay any amount outstanding
under this Note, during the 31st through 60 day period after the issuance of this Note, by making a payment to the
Holder of an amount in cash equal to 117% multiplied the amount that the Borrower is prepaying, subject to the Holder’s
prior written acceptance in Holder’s sole discretion. Notwithstanding anything to the contrary contained in this Note, the
Borrower may prepay any amount outstanding under this Note, during the 61st through 90 day period after the issuance
of this Note, by making a payment to the Holder of an amount in cash equal to 122% multiplied the amount that the Borrower is
prepaying, subject to the Holder’s prior written acceptance in Holder’s sole discretion. Notwithstanding anything
to the contrary contained in this Note, the Borrower may prepay any amount outstanding under this Note, during the 91st
through 120 day period after the issuance of this Note, by making a payment to the Holder of an amount in cash equal to 127% multiplied
the amount that the Borrower is prepaying, subject to the Holder’s prior written acceptance in Holder’s sole discretion.
Notwithstanding anything to the contrary contained in this Note, the Borrower may prepay any amount outstanding under this Note,
during the 121st through 150 day period after the issuance of this Note, by making a payment to the Holder of an amount
in cash equal to 132% multiplied the amount that the Borrower is prepaying, subject to the Holder’s prior written acceptance
in Holder’s sole discretion. Notwithstanding anything to the contrary contained in this Note, the Borrower may prepay any
amount outstanding under this Note, during the 151st through 180 day period after the issuance of this Note, by making
a payment to the Holder of an amount in cash equal to 137% multiplied the amount that the Borrower is prepaying, subject to the
Holder’s prior written acceptance in Holder’s sole discretion. The Borrower may not prepay any amount outstanding
under this Note after the 180th day after the issuance of this Note.

 

    	 	14	 

     

    

 

4.10        Usury.
If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury,
the applicable provision shall automatically be revised to equal the maximum rate of interest or other amount deemed interest
permitted under applicable law. The Borrower covenants (to the extent that it may lawfully do so) that it shall not seek to claim
or take advantage of any law that would prohibit or forgive the Borrower from paying all or a portion of the principal or interest
on this Note.

 

4.11        Section
3(a)(10) Transactions. If at any time while this Note is outstanding, the Borrower enters into a transaction structured in
accordance with, based upon, or related or pursuant to, in whole or in part, Section 3(a)(10) of the Securities Act (a “3(a)(10)
Transaction”), then a liquidated damages charge of 25% of the outstanding principal balance of this Note at that time, will
be assessed and will become immediately due and payable to the Holder, either in the form of cash payment or as an addition to
the balance of the Note, as determined by mutual agreement of the Borrower and Holder.

 

4.12        Reverse
Split Penalty. If at any time while this Note is outstanding, the Borrower effectuates a reverse split with respect to the
Common Stock, then a liquidated damages charge of 15% of the outstanding principal balance of this Note at that time, will be
assessed and will become immediately due and payable to the Holder, either in the form of cash payment or as an addition to the
balance of the Note, as determined by mutual agreement of the Borrower and Holder.

 

4.13        Right
of First Refusal. If at any time while this Note is outstanding, the Borrower has a bona fide offer of capital or financing
from any 3rd party, that the Borrower intends to act upon, then the Borrower must first offer such opportunity to the Holder to
provide such capital or financing to the Borrower on the same terms as each respective 3rd party’s terms. Should the Holder
be unwilling or unable to provide such capital or financing to the Borrower within 10 trading days from Holder’s receipt
of written notice of the offer (the “Offer Notice”) from the Borrower, then the Borrower may obtain such capital or
financing from that respective 3rd party upon the exact same terms and conditions offered by the Borrower to the Holder, which
transaction must be completed within 30 days after the date of the Offer Notice. If the Borrower does not receive the capital
or financing from the respective 3rd party within 30 days after the date of the respective Offer Notice, then the Borrower must
again offer the capital or financing opportunity to the Holder as described above, and the process detailed above shall be repeated.
The Offer Notice must be sent via electronic mail to Info@CrownBridgeCapital.com.

 

4.14        ACH
Option. Notwithstanding anything contained herein to the contrary, upon the occurrence of an Event of Default, at the Holder’s
option, in addition to the right to conversion as set forth above and any other rights and remedies as set forth herein, the Holder
may deduct daily ACH payments from the bank account of the Borrower (or any of its subsidiaries) in the amount of $1,500.00
per day until such time as the Borrower has paid (or the Holder has converted) an amount equal to the principal balance, interest,
accrued interest, Default Amount and any other fees as set forth in the Note.

 

    	 	15	 

     

    

 

[signature page to follow]

 

    	 	16	 

     

    

 

IN WITNESS WHEREOF, Borrower has caused
this Note to be signed in its name by its duly authorized officer this October 25, 2017.

 

	DRONE USA, INC.	 
	 	 	 
	By:	/s/ Michael Bannon	 
	Name: Michael Bannon	 
	Title: Chief Executive Officer	 

 

    	 	17	 

     

    

 

EXHIBIT A -- NOTICE OF CONVERSION

 

The undersigned hereby
elects to convert $                           principal
amount of the Note (defined below) into that number of shares of Common Stock to be issued pursuant to the conversion of the Note
(“Common Stock”) as set forth below, of DRONE USA, INC., a Delaware corporation (the “Borrower”) according
to the conditions of the convertible note of the Borrower dated as of October 25, 2017 (the “Note”), as of the date
written below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any.

 

Box Checked as to applicable instructions:

 

		 ̈	The Borrower shall electronically transmit the Common
Stock issuable pursuant to this Notice of Conversion to the account of the undersigned or its nominee with DTC through its Deposit
Withdrawal Agent Commission system (“DWAC Transfer”).

 

Name of DTC Prime Broker:

Account Number:

 

		 ̈	The undersigned hereby requests that the Borrower issue
a certificate or certificates for the number of shares of Common Stock set forth below (which numbers are based on the Holder’s
calculation attached hereto) in the name(s) specified immediately below or, if additional space is necessary, on an attachment
hereto:

 

CROWN BRIDGE PARTNERS, LLC

1173a 2nd Avenue,
Suite 126 

New York, NY 10065

e-mail: Info@CrownBridgeCapital.com

 

	Date of Conversion:	______________
	Applicable Conversion Price:	$_____________
	Number of Shares of Common Stock to be Issued	 
	Pursuant to Conversion of the Notes:	_______________
	Amount of Principal Balance Due remaining	 
	Under the Note after this conversion:	_______________

 

CROWN BRIDGE PARTNERS, LLC

 

	By: 	 	 
	Name: 	 	 
	Title: 	 	 
	Date: 	 	 

 

    	 	18	 

     

    

 

EXHIBIT B – CONFESSION OF JUDGMENT

 

(see attached)

 

    	 	19	 

     

    

 

	SUPREME COURT OF THE STATE OF NEW YORK	 	 
	COUNTY OF NEW YORK	 	 
	----------------------------------------------------------------------- 	X	 
	CROWN BRIDGE PARTNERS, LLC,	 	 
	 	 	Index No.
	Plaintiff,	 	 
	 	 	AFFIDAVIT OF
	 	 	CONFESSION OF
	- against -	 	JUDGMENT
	 	 	 
	DRONE USA, INC.,	 	 
	Defendant.	 	 
	----------------------------------------------------------------------- 	X	 

 

	STATE OF NEW YORK	)	 	 
	 	)	ss.:	 
	COUNTY OF NEW YORK	)	 	 

 

Michael Bannon (the “Guarantor”),
being duly sworn, hereby deposes and says:

 

1.           I
am the Chief Executive Officer of defendant DRONE USA, INC. (the “Company”), a Delaware corporation. The Guarantor
and the Company shall collectively be referred to herein as the “Borrower”. The Guarantor shall be personally and severally
liable hereunder, in addition to the Company. As such, I am fully familiar with all the facts and circumstances recited herein
on personal knowledge. The Borrower has its principal place of business at 16 Hamilton Street, West Haven, CT 06516. On behalf
of Borrower, and in my individual capacity, I hereby confess judgment against the Borrower in favor of Crown Bridge Partners, LLC
(“Crown Bridge”), with a principal place of business located at 1173a 2nd Avenue, Suite 126, New York, NY
10065, in the amount of Three Hundred Fifteen Thousand Dollars ($315,000.00), less any unfunded tranches under the Note (as defined
below), payments made on or after the date of this affidavit of confession of judgment (the “Confession of Judgment”),
and conversions under the Note made on or after the date of this Confession of Judgment, plus interest at the rate(s) identified
in the Note on said amount and all applicable penalties under the Note. In no event shall interest payable hereunder exceed the
maximum permissible under applicable law.

 

    	 	20	 

     

    

 

2.           This
Confession of Judgment is for a debt justly due to Crown Bridge from me and the Borrower, and the Company hereby authorizes the
Supreme Court of the State of New York to enter judgment against the Borrower, in the amount of Three Hundred Fifteen Thousand
Dollars ($315,000.00), less any unfunded tranches under the Note, payments made on or after the date of this Confession of Judgment,
and conversions under the Note made on or after the date of this Confession of Judgment, plus interest at the rate(s) identified
in the Note on said amount, all applicable penalties under the Note, and costs and attorneys’ fees that are set forth below,
upon the occurrence of an event of default under that certain convertible promissory note, in the original principal amount of
Three Hundred Fifteen Thousand Dollars ($315,000.00), issued by the Borrower to Crown Bridge on October 25, 2017 (the “Note”).

 

3.           In
order to secure these obligations, the Borrower agreed to deliver this Confession of Judgment. The Borrower hereby authorizes entry
of a monetary judgment obtained pursuant to the Confession of Judgment in the New York State Supreme Court, New York County.

 

4.           The
sums confessed pursuant to this Confession of Judgment are justly due and owing to Crown Bridge under the following circumstances:
the Company and Crown Bridge entered into a securities purchase agreement, (the “Agreement”) dated October 25, 2017,
and the related Note. The Agreement provides for the issuance of the Note, and contains customary representations, warranties,
and covenants.

 

5.           The
Borrower agrees to pay any and all costs and expenses incurred by Crown Bridge in enforcing the terms of this Confession of Judgment,
including reasonable attorneys’ fees and expenses at the rate of $475.00 per hour that Crown Bridge incurs or is billed for
in connection with enforcing the terms of the Confession of Judgment, entering a monetary judgment in the New York State Supreme
Court, collecting upon said judgment, and defending or prosecuting any appeals.

 

[Signature page to follow]

 

    	 	21	 

     

    

 

	 	By: 	/s/ Michael Bannon
	 	Name: 	Michael Bannon, an individual

 

	 	DRONE USA, INC.

 

	 	By: 	/s/ Michael Bannon
	 	Name: 	Michael Bannon
	 	Title: 	Chief Executive Officer

 

    	 	22	 

     

    

 

STATE OF _______________    )

 

ss.

 

COUNTY OF _______________    )

 

ACKNOWLEDGMENT

 

On ___________, 2017 before me personally came
Michael Bannon, to me known, who, by me duly sworn, did depose and say that deponent is the Chief Executive Officer of DRONE USA,
INC., the corporation described in, and which executed the foregoing affidavit of confession of judgment, that deponent knows the
seal of the corporation, that the seal affixed to the affidavit of confession of judgment is the corporation’s seal, that
it was affixed by order of the board of directors of the corporation and that deponent signed deponent’s name by like order.

 

_____________________________

Notary Public

 

    	 	23Blueprint

EXECUTION VERSION

 

Exhibit 10.2

 

 

Binding Term Sheet for Joint Venture Agreement

 

September
25, 2017

 

This
term sheet (“Term Sheet”) sets out the key terms of a
proposed transaction for a joint venture between SANUWAVE Health
Inc. of 3360 Martin Farm Road, Suite 100, Suwanee, Georgia, 30024,
United States (“Sanuwave”), and MundiMed Distribuidora
Hospitalar LTDA of of Rua Manoel Gomes dos Santos, 1173 –
Jardim Sumaré – Cravinhos/SP Brazil
(“MundiMed”). Each of Sanuwave and MundiMed are
referred to herein as a “Party” and collectively, as
the “Parties”.

 

The
Parties are engaged in the negotiation of terms of a proposed joint
venture (the “Joint Venture”) for the establishment of
a business (the “Business”) for the sole purpose of the
manufacture, sale and distribution of a Sanuwave proprietary,
patented medical device (the “Device”). The purpose of
this Term Sheet is to confirm to-date the agreement among the
Parties concerning certain terms of the proposed Joint
Venture.

 

The
Parties will continue to work together in good faith to enter into
a definitive agreement reflecting these terms (the
“Definitive Agreement”). In the event a Definitive
Agreement has not been executed by the Parties by September 30,
2017, the terms set forth in this Term Sheet will be binding on the
Parties.

 

Financial Terms:

 

	

Partnership
Fee:

	

MundiMed
shall pay to Sanuwave the aggregate amount of USD

[****](the
“Partnership Fee”) as follows:

(1) USD
[****] on September 30, 2017; and

(2) USD [****]
in equal monthly installments payable over a period of eighteen
(18) months, commencing November 30, 2017, and on the 30th day (or
the following business day if the 30th day of a given month does
not fall on a business day) of each month thereafter.

 

	

Organizational
Expenses:

	

MundiMed
shall bear the cost of any and all fees and expenses incurred in
connection with the formation, organization and startup of the
Joint Venture, expected not to exceed USD $200,000.

 

 

 

 
1

[****]
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,
MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

 

	

Profit-Sharing:

	

Any
profits distributed by the Joint Venture shall be distributed
between MundiMed, Sanuwave, LHS Latina Health Solutions Gestão
Empresarial LTDA a company organized under the laws of Brazil
(“Latina Health”) and Universus Global Advisors LLC, a
Delaware limited liability company (“Universus Global”)
(MundiMed, Sanuwave, Latina Health and Universus Global are
collectively referred to herein as the “Profit Sharing
Recipients”). Each of MundiMed and Sanuwave shall receive an
amount equal to 45% of such profits and each of Latina Health and
Universus Global shall receive an amount equal to 5% of such
profits.

 

	

Miscellaneous
Terms:

	

MundiMed
shall purchase two to six Devices from the Joint Venture on or
before December 31, 2017, and the Joint Venture shall sell such
Devices to MundiMed in exchange for payment of the total purchase
price in cash. These devices shall be used by targeted parties to
do experimental, pre-approved work. The foregoing obligations of
the Parties are subject to the advice of legal counsel that the
consummation of such purchase(s) and sale(s) will not constitute a
material violation of applicable government
regulations.

 

	

Term
and Termination:

	

This
Term Sheet shall be effective as of the date this Term Sheet is
executed by both Parties and shall continue until the earlier to
occur of (a) the date the Definitive Agreement is fully-executed by
both Parties and (b) May 30, 2019. In the event the Definitive
Agreement has not been executed by both Parties by September 30,
2017, this Term Sheet shall continue to be in effect as of such
date.

Notwithstanding
the foregoing, this Term Sheet may be terminated by either Party
for a material breach of its terms by the other Party (following an
applicable cure period) where it is reasonably foreseeable that
such material breach could result in a material adverse effect on
the business, financials or results of operations of the
non-breaching Party.

Upon
the termination of the Term Sheet all rights granted to MundiMed
under the Term Sheet, as applicable, shall revert to Sanuwave and
MundiMed shall promptly pay to Sanuwave all payments due and
payable to Sanuwave as of the termination, return all materials
provided to MundiMed by Sanuwave under the Term Sheet, as
applicable, and all tangible embodiments of any and all proprietary
information disclosed to MundiMed by Sanuwave in connection with
the proposed Business, as applicable, and provide Sanuwave with a
certificate of such return.

 

 

 
2

[****]
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,
MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

 

	
 

	

Notwithstanding
the foregoing, the provisions set forth opposite the
“Confidentiality” and “Integration”
headings in this Term Sheet shall survive termination.

 

	

Confidentiality:

	

This
Term Sheet, the MOU, their respective contents, and the fact that
the Parties are engaged in discussions regarding a potential joint
venture shall constitute confidential information. The Parties
hereby agree not to disclose the existence of such discussions, the
Term Sheet, MOU or the respective contents thereof; provided,
however, that the Parties may disclose the foregoing to their
respective attorneys, accountants and any other party who has a
“need to know” basis warranting disclosure.
Notwithstanding the foregoing, the Parties hereby acknowledge that
Sanuwave is subject to certain securities laws, compliance with
which may require the disclosure of confidential information. The
Parties hereby agree that Sanuwave may disclose confidential
information in connection with its ongoing reporting requirements
under applicable securities laws and pursuant to any other acts it
may take in connection with its obligation to comply with such
securities laws.

 

	

Governing
Law:

	

This
Term Sheet, the MOU are, and any Definitive Agreement will be,
governed by and interpreted in accordance with the laws of the
State of New York, United States of America, without regard to
conflict of laws provisions thereof.

 

	

General:

	

This
Term Sheet constitutes the entire agreement and understanding of
the Parties as to the terms set forth in this Term Sheet and
supersedes all communication between the Parties related to the
terms set forth in this Term Sheet, and all prior agreements, oral
or written, including the terms of the Memorandum of Understanding
by and between the Parties, dated August 13, 2017 (the
“MOU”), to the extent of the subject matter of the
terms included in this Term Sheet, including, but not limited to,
the confidentiality, governing law and integration provisions set
forth herein. For the avoidance of doubt, the MOU shall remain in
full force and effect to the extent the terms of the MOU are not
the subject matter of this Term Sheet. This Term Sheet shall be
binding upon and inure to the benefit of and be enforceable by the
Parties respective successors and permitted assigns. Nothing in
this Term Sheet shall confer any rights upon any person or entity
other than the Parties and their respective successors and
permitted assigns. No Party may assign this Term Sheet or any of
its rights hereunder to any person or entity without the prior
written consent of the other Party. This Term Sheet may be amended
or modified only by a writing executed by both
Parties.

 

 

 

 
3

[****]
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,
MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

 

IN
WITNESS WHEREOF, this Term Sheet is effective as of the date first
set forth above. This Term Sheet may be executed in counterparts,
each of which shall constitute an original and all of which, when
taken together, shall constitute the entire document and may be
executed by electronically scanned or “pdf”
signatures.

 

 

	

SANUWAVE
Health Inc.

 

 

/s/ Kevin A. Richardson II

Name:
Kevin A. Richardson II

Title:
Chairman & CEO

	

MundiMed
Distribuidora Hospitalar LTDA

 

 

/s/ Alessandro Cardim

Name:
Alessandro Cardim

Title:
Director

 

 

 

	

LHS
Latina Health Solutions

Gestão
Empresarial LTDA

 

 

/s/ Mauricio Grimoni

Name:
Mauricio Grimoni

Title:
CEO

	

Universus
Global Advisors LLC

 

 

 

/s/ Michael Hubert

Name:
Michael Hubert

Title:
Managing Member

 

 

 

 
4

[****]
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT,
MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]